Tzvi Palash - Net Worth and Insider Trading
Tzvi Palash Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Tzvi Palash owns 1 companies in total, including Protalix BioTherapeutics Inc (PLX) .
Click here to see the complete history of Tzvi Palash’s form 4 insider trades.
Insider Ownership Summary of Tzvi Palash
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
PLX | Protalix BioTherapeutics Inc | 2012-07-16 | Chief Operating Officer |
Tzvi Palash Trading Performance
Tzvi Palash Ownership Network
Ownership Network List of Tzvi Palash
Ownership Network Relation of Tzvi Palash
Tzvi Palash Owned Company Details
What does Protalix BioTherapeutics Inc do?
Who are the key executives at Protalix BioTherapeutics Inc?
Tzvi Palash is the Chief Operating Officer of Protalix BioTherapeutics Inc. Other key executives at Protalix BioTherapeutics Inc include director & President and CEO Dror Bashan , 10 percent owner Dexcel Pharma Technologies Ltd. , and 10 percent owner Dan Oren .
Protalix BioTherapeutics Inc (PLX) Insider Trades Summary
Over the past 18 months, Tzvi Palash made no insider transaction in Protalix BioTherapeutics Inc (PLX). Other recent insider transactions involving Protalix BioTherapeutics Inc (PLX) include a net purchase of 64,516 shares made by Dror Bashan ,
In summary, during the past 3 months, insiders sold 0 shares of Protalix BioTherapeutics Inc (PLX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Protalix BioTherapeutics Inc (PLX) were sold and 64,516 shares were bought by its insiders, resulting in a net purchase of 64,516 shares.
Protalix BioTherapeutics Inc (PLX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Protalix BioTherapeutics Inc Insider Transactions
Tzvi Palash Mailing Address
Above is the net worth, insider trading, and ownership report for Tzvi Palash. You might contact Tzvi Palash via mailing address: 2 Snunit Street, Science Park, Pob 455, Carmiel L3 20100.